1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Samsung Biologics Co.,Ltd.
  6. News
  7. Most relevant
    A207940   KR7207940008

SAMSUNG BIOLOGICS CO.,LTD.

(A207940)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about SAMSUNG BIOLOGICS CO.,LTD.
05/16South Korea’s Leading Index Kospi Slips on Fears over Rate Hikes Across Economies..
MT
04/29SAMSUNG BIOLOGICS : Decision on Acquisition of Tangible Assets
PU
04/28South Korea’s Kospi Adds 1% on Stellar Q1 Earnings; Samsung Biologics Adds 3%
MT
04/28Samsung Biologics' Net Income Surges 141% in March Quarter
MT
04/28Samsung Biologics Completes Full Acquisition Of Samsung Bioepis
AQ
04/27SAMSUNG BIOLOGICS : Material Business Matters Related to Investment Decisions
PU
04/21SAMSUNG BIOLOGICS : Results of issuance (Voluntary Disclosure)
PU
04/05Allakos Inc. Enters into A Master Development Services Agreement with Samsung Biologics..
CI
04/01Samsung C&T - Samsung Life Science Fund makes first investment in US biotech firm Jagua..
AQ
03/30SAMSUNG BIOLOGICS : Decision on Acquisition of Tangible Assets
PU
03/30SAMSUNG BIOLOGICS : Conclusion of Single SalesContract or Supply Contract
PU
03/24South Korea’s Kospi Falls on Higher Energy Costs, Geopolitical Woes; Samsung Elec..
MT
03/23COVID vaccine maker Moderna flags Japan ambition with sumo sponsorship
RE
03/03SAMSUNG BIOLOGICS : Submission of Audit Report
PU
03/03SAMSUNG BIOLOGICS : Issuing Price of New Shares Issued by Paid-in Capital Increase
PU
03/02Samsung Biologics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31..
CI
03/01Samsung Bioepis Secures 10 Biosimilar Products over 10 Years
MT
01/31Quarterhill CFO John Rim Quits; Subsidiary ETC Gets US$49.3 Million Subcontract
MT
01/31QUARTERHILL BRIEF : Announces Departure of John Rim, CFO; Also Says Co Subsidiary, ETC, to..
MT
01/27Samsung Biologics to Buy Biogen's Stake in JV
DJ
01/25Samsung Biologics' Q4 Net Profit Slumps, Revenue Jumps
MT
01/18S.Korea stocks hit 7-week closing low ahead of LGES IPO
RE
01/18SAMSUNG BIOLOGICS : Prior Notice on Disclosure of Final Earnings
PU
01/14South Korean Stocks Fall for Second Day as Bank of Korea Raises Base Rate; Samsung Biol..
MT
01/13Samsung Biologics to Start Building Fifth Plant to Meet Higher Biopharmaceutical Produc..
MT
01/13S.Korean stocks end lower on options expiry; BOK in focus
RE
01/12South Korean Stocks Jump After US Fed Chief’s Less Hawkish Testimony; Hanmi Pharm..
MT
01/12S.Korean stocks post best day in 6 weeks on Powell remarks
RE
01/03S.Korea stocks begin 2022 with mild gains on trade data boost
RE
2021Wall Street closes down, indexes still poised for big annual gains
RE
2021Samsung BioLogics says report on Biogen deal talks untrue
RE
2021Dow touches record high as unemployment claims slip
RE
2021Biogen Shares Give Up Gains as Samsung Denies Takeover Rumor
DJ
2021SOUTH KOREA'S PRIMARY BENCHMARK KOSP : Nomura
MT
2021S.Korea stocks end higher as Fed decision calms nerves
RE
2021South Korean Stocks Decline Ahead of US Fed’s Policy Decision; Samsung Biologics ..
MT
2021Samsung Biologics to Produce AstraZeneca's COVID-19 Antibody Combination AZD7442
MT
2021S.Korea stocks fall for 3rd day on caution over cenbank meetings
RE
2021S.Korea stocks ease off 7-week high on caution ahead of Fed meeting
RE
2021South Korean Stocks Rise as Investors Move Past Omicron Fears; LG Chem Adds 6%
MT
2021Samsung Biologics, GreenLight Biosciences Enter Deal to Produce COVID-19 mRNA Vaccines
MT
2021South Korean Stocks Fall for Fifth Session Over COVID-19 Variant Omicron Fears; Hyundai..
MT
2021GreenLight Biosciences and Samsung Biologics Announce Collaboration to Build Capacity f..
CI
2021Immunovant Sciences Gmbh Enters into Product Service Agreement with Samsung Biologics C..
CI
2021South Korea’s Indexes Decline on Profit-Taking; Naver, LG Chem Decline over 2%
MT
2021South Korean Stocks Break Three-Day Losses to Close Higher; Samsung Biologics Jumps 6% ..
MT
2021Samsung Biologics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2021Samsung's Lee visits U.S ahead of likely $17 billion chip plant decision-media
RE
2021S.Korea stocks end 1% higher on chip, biopharma boost, U.S. data in focus
RE
2021South Korea Stocks Decline as Investors Eye US, China Inflation Data; Biopharma Stocks ..
MT
2021S.Korean stocks end at near 1-month low as biopharma shares slump
RE
2021Samsung Biologics Eyes Expansion in US, Europe
MT
2021Private S.Korea firms plan $5.4 billion investment to create vaccine hub
RE
2021South Korea Stocks Fall on Profit-Taking; Samsung Electronics Loses 1%
MT
2021Samsung Biologics' Net Attributable Income Surges 135% in Q3
MT
2021Samsung Biologics Co.,Ltd. Provides Revenue Guidance for the Year 2021
CI
2021S.Korea approves Moderna's COVID-19 vaccine produced by Samsung Biologics
RE
2021S.Korean stocks rebound on tech boost, easing China property woes
RE
2021South Korean Stocks Slip on Slower Economy Growth in China, Highest Oil Prices in Years
MT
2021South Korean Stocks Close Higher on Chip Shares' Gains; Samsung, SK Hynix Move Markets
MT
2021SAMSUNG BIOLOGICS : Enzolytics Sign Deal for Anti-HIV, Anti-COVID-19 Monoclonal Antibody T..
MT
2021Enzolytics Inc. and Samsung Biologics Co., Ltd. Announce Development and Manufacturing ..
CI
2021Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021,..
CI
2021Biogen, Samsung Bioepis Get FDA OK for Lucentis Biosimilar
DJ
2021South Korea Stocks Rise on Upbeat August US Retail Sales; Samsung Electronics Adds 1%
MT
2021Samsung Biologics Joins Frontier 1.5D Project as Part of 2050 Carbon Neutral Initiative
CI
2021KOSPI COMPOSITE INDEX : South Korea Stocks Gain Marginally as Investors' Await US Fed Chie..
MT
2021MARKET CHATTER : Samsung Biologics Eyes Inaugural Public Bond Offering
MT
2021SAMSUNG BIOLOGICS : European Commission Grants Marketing Approval to Samsung Bioepis' Luce..
MT
2021Samsung to invest $206 bln by 2023 for post-pandemic growth
RE
2021S.Korean stocks end at over four-month low on taper, virus fears
RE
2021SAMSUNG BIOLOGICS : leader returns to court a week after being released
AQ
2021MARKET CHATTER : Samsung Bioepis' Biosimilar Sales Globally Surge 30% in H1
MT
2021S.Korea pledges nearly $2 bln to become major COVID-19 vaccine producer
RE
2021SAMSUNG BIOLOGICS' : Net Profit Surges over 130% in Q2
MT
1  2  3  4Next
Upcoming event on SAMSUNG BIOLOGICS CO.,LTD.